Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis

被引：0
|
作者：
Giuseppe Rosiello
Carlotta Palumbo
Sophie Knipper
Angela Pecoraro
Stefano Luzzago
Pierre-Antoine St-Hilaire
Zhe Tian
Umberto Capitanio
Francesco Montorsi
Shahrokh F. Shariat
Fred Saad
Alberto Briganti
Pierre I. Karakiewicz
机构：
[1] University of Montreal Health Center,Cancer Prognostics and Health Outcomes Unit, Division of Urology
[2] IRCCS San Raffaele Scientific Institute,Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute
[3] University of Brescia,Urology Unit, ASST Spedali Civili of Brescia, Department of Medical and Surgical Specialties, Radiological Science and Public Health
[4] University Hospital Hamburg-Eppendorf,Martini
[5] University of Turin,Klinik Prostate Cancer Center
[6] European Institute of Oncology,Department of Urology, San Luigi Gonzaga Hospital
[7] Medical University of Vienna,Department of Urology
[8] I.M. Sechenov First Moscow State Medical University,Department of Urology, Comprehensive Cancer Center
来源：
World Journal of Urology | 2021年 / 39卷
关键词：
Combination therapy; Cytoreductive nephrectomy; Histology; Kidney cancer; SEER database; Targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：461 / 472
页数：11
相关论文
共 50 条
  • [41] Ferroptosis-Related Gene Signature Accurately Predicts Survival Outcomes in Patients With Clear-Cell Renal Cell Carcinoma
    Chang, Kaili
    Yuan, Chong
    Liu, Xueguang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [42] Paratesticular Clear Cell Papillary Cystadenomas: A Morphologic and Immunohistochemical Comparison with Metastatic Renal Cell Carcinoma
    Morrison, Casey
    Chan, Emily
    Acosta, Andres
    Panizo, Angel
    Williamson, Sean
    Mubeen, Aysha
    Nova-Camacho, Luiz
    Sangoi, Ankur
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1022 - S1023
  • [43] PROGNOSTIC DIFFERENCES AND SURVIVAL OUTCOMES IN PATIENTS WITH PAPILLARY RENAL CELL CARCINOMA SUBTYPES - A COMPARISON BETWEEN TYPE I VS. TYPE II
    Rosiello, Giuseppe
    Muttin, Fabio
    Nini, Alessandro
    Baiamonte, Gianfranco
    Bravi, Carlo Andrea
    Bandini, Marco
    Martini, Alberto
    Luca, Villa
    Trevisani, Francesco
    Montorsi, Francesco
    Salonia, Andrea
    Briganti, Alberto
    Bertini, Roberto
    Larcher, Alessandro
    Capitanio, Umberto
    JOURNAL OF UROLOGY, 2020, 203 : E1225 - E1225
  • [44] Annexin II represents metastatic potential in clear-cell renal cell carcinoma
    Y Ohno
    M Izumi
    T Kawamura
    T Nishimura
    K Mukai
    M Tachibana
    British Journal of Cancer, 2009, 101 : 287 - 294
  • [45] Annexin II represents metastatic potential in clear-cell renal cell carcinoma
    Ohno, Y.
    Izumi, M.
    Kawamura, T.
    Nishimura, T.
    Mukai, K.
    Tachibana, M.
    BRITISH JOURNAL OF CANCER, 2009, 101 (02) : 287 - 294
  • [46] A Novel Cuprotosis-Related Gene Signature Predicts Survival Outcomes in Patients with Clear-Cell Renal Cell Carcinoma
    Zhan, Zhenrun
    Han, Pengyong
    Bi, Xiaodan
    Yang, Jinpeng
    Zhao, Tingting
    INTELLIGENT COMPUTING THEORIES AND APPLICATION, ICIC 2022, PT II, 2022, 13394 : 260 - 269
  • [47] Vascular Pattern and Density in Clear Cell vs Clear Cell Papillary Renal Cell Carcinoma
    Canete-Portillo, S.
    Pena, M. Rodriguez
    Wang, D.
    Netto, G. J.
    Magi-Galluzzi, C.
    Sanchez, D. F.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 154 : S78 - S78
  • [48] Etiologic heterogeneity of clear-cell and papillary renal cell carcinoma in the Netherlands Cohort Study
    van de Pol, Jeroen A. A.
    George, Lisa
    van den Brandt, Piet A.
    Baldewijns, Marcella M. L. L.
    Schouten, Leo J.
    INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (01) : 67 - 76
  • [49] High expression of Aldolase A predicts poor survival in patients with clear-cell renal cell carcinoma
    Na, Ning
    Li, Heng
    Xu, Chengfang
    Miao, Bin
    Hong, Liangqing
    Huang, Zhengyu
    Jiang, Qiu
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 279 - 285
  • [50] PROPENSITY SCORE-MATCHED ANALYSIS OF NEOADJUVANT VS. ADJUVANT THERAPY IN RENAL CELL CARCINOMA
    Cesare, Saitta
    Mimi, V. Nguyen
    Giacomo, Musso
    Kevin, Hakimi
    Dattatraya, Patil
    Hajime, Tanaka
    Luke, Wang
    Margaret, F. Meagher
    Dhruv, Puri
    Kit, Yuen
    Masaki, Kobayashi
    Shohei, Fukuda
    Giuseppe, Garofano
    Giovanni, Lughezzani
    Nicolo, Buffi
    Viraj, Master
    Ithaar, H. Derweesh
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
12345